This is a prerecorded session from the 2020 Spring Virtual Conference held on April 25, 2020. (All questions and answers were recorded live. For answers to other questions, please email help@aamds.org or call (800) 747-2820, option 2.)
Dr. Daniel Pollyea, MD, MS from the University of Colorado Health explained the definition of High-Risk MDS, or Myelodysplastic Syndromes, as well as how it can change into AML, or Acute Myeloid Leukemia. He answered questions from the live audience in this recording.
Негізгі бет MDS - AML - 2020 Spring Virtual Conference: When MDS becomes AML - for High-Risk MDS Patients
Пікірлер